Q1 2023 Earnings Forecast for Encompass Health Co. (NYSE:EHC) Issued By William Blair

Encompass Health Co. (NYSE:EHC – Get Rating) – William Blair cut their Q1 2023 earnings estimates for shares of Encompass Health in a research note issued on Tuesday, August 2nd. William Blair analyst M. Larew now expects that the company will post earnings of $0.96 per share for the quarter, down from their previous forecast of $1.06. The consensus estimate for Encompass Health’s current full-year earnings is $3.02 per share. William Blair also issued estimates for Encompass Health’s Q2 2023 earnings at $0.99 EPS and Q3 2023 earnings at $0.97 EPS.

Encompass Health (NYSE:EHC – Get Rating) last released its quarterly earnings data on Monday, August 1st. The company reported $0.89 earnings per share for the quarter, missing analysts’ consensus estimates of $0.97 by ($0.08). The firm had revenue of $1.33 billion during the quarter, compared to analysts’ expectations of $1.34 billion. Encompass Health had a net margin of 6.22% and a return on equity of 16.20%. The firm’s quarterly revenue was up 3.3% on a year-over-year basis. During the same period in the previous year, the firm posted $1.17 EPS.

A number of other research analysts have also issued reports on EHC. Barclays decreased their target price on Encompass Health from $80.00 to $63.00 and set an “overweight” rating on the stock in a research report on Thursday. Truist Financial cut their target price on shares of Encompass Health from $85.00 to $75.00 and set a “buy” rating for the company in a research note on Tuesday, June 21st. StockNews.com lowered shares of Encompass Health from a “buy” rating to a “hold” rating in a research note on Wednesday. Raymond James cut their price objective on Encompass Health from $70.00 to $65.00 and set a “strong-buy” rating for the company in a research note on Thursday. Finally, BMO Capital Markets decreased their target price on Encompass Health from $83.00 to $65.00 and set an “outperform” rating on the stock in a research report on Thursday. One investment analyst has rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company has an average rating of “Buy” and an average target price of $74.60.

Encompass Health Stock Up 0.1 %

Shares of EHC opened at $52.91 on Thursday. The firm has a market cap of $5.28 billion, a P/E ratio of 16.17, a PEG ratio of 2.41 and a beta of 0.91. Encompass Health has a 12 month low of $44.33 and a 12 month high of $81.45. The stock’s 50 day moving average is $54.14 and its two-hundred day moving average is $62.81. The company has a current ratio of 1.24, a quick ratio of 1.26 and a debt-to-equity ratio of 1.29.

Encompass Health Cuts Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, October 17th. Shareholders of record on Monday, October 3rd will be issued a $0.15 dividend. This represents a $0.60 annualized dividend and a yield of 1.13%. The ex-dividend date of this dividend is Friday, September 30th. Encompass Health’s payout ratio is currently 34.25%.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of EHC. Bank of Montreal Can raised its stake in Encompass Health by 1.5% during the first quarter. Bank of Montreal Can now owns 11,340 shares of the company’s stock worth $806,000 after purchasing an additional 173 shares during the period. Exchange Traded Concepts LLC grew its position in Encompass Health by 2.3% in the second quarter. Exchange Traded Concepts LLC now owns 9,996 shares of the company’s stock worth $560,000 after acquiring an additional 228 shares during the period. Legacy Wealth Asset Management LLC increased its stake in Encompass Health by 2.7% during the first quarter. Legacy Wealth Asset Management LLC now owns 9,399 shares of the company’s stock worth $668,000 after acquiring an additional 250 shares during the last quarter. Baird Financial Group Inc. raised its position in Encompass Health by 2.5% in the fourth quarter. Baird Financial Group Inc. now owns 11,481 shares of the company’s stock valued at $750,000 after purchasing an additional 276 shares during the period. Finally, Allworth Financial LP raised its position in Encompass Health by 83.1% in the first quarter. Allworth Financial LP now owns 630 shares of the company’s stock valued at $45,000 after purchasing an additional 286 shares during the period. Institutional investors and hedge funds own 91.70% of the company’s stock.

About Encompass Health

(Get Rating)

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.